Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP

Magnetic Resonance in Medicine

Volumn 35, Issue 1, 1996, Pages 14-19

  Gallez, Bernard ^a,b   Bacic, Goran ^a   Swartz, Harold M ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Laboratory of Medicinal Chemistry   (Belgium)

Author keywords

31P NMR spectroscopy; EPR; Mn DPDP; Relaxivity

Indexed keywords

DISSOCIATION; ELECTRON SPIN RESONANCE SPECTROSCOPY; MAGNETIC RESONANCE; MANGANESE METALLOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARAMAGNETIC RESONANCE;

31P-NMR SPECTROSCOPY; CALCIUM AND MAGNESIUMS; EPR SPECTROSCOPY; INTRAVENOUS INJECTIONS; MRI CONTRAST AGENTS; PHYSIOLOGICAL CONCENTRATIONS; RELAXIVITY; RESONANCE TECHNIQUE;

MANGANESE COMPOUNDS;

CALCIUM ION; MAGNESIUM ION; MANGAFODIPIR; MANGANESE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DISSOCIATION; ELECTRON SPIN RESONANCE; INTRAVENOUS DRUG ADMINISTRATION; LIVER HOMOGENATE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE;

EID: 0030048405     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910350104     Document Type: Article

References (47)

1. G. Schuhmann-Giampieri, H. Schmitt, W. R. Press, C. Negishi, H.-J. Weimann, U. Speck, Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 183, 59-64 (1992).
2. B. P. Kreft, A. Tanimoto, D. D. Stark, Y. Baba, C. C. Compoton, J. P. Finn, F. M. Cavagna, Enhancement of tumor-liver contrast-to-noise ratio with gadobenate dimeglumine in MR imaging of rats. J. Magn. Reson. Imaging 3, 41-49 (1993).
3. S. M. Rocklage, W. P. Cacheris, S. C. Quay, F. E. Hahn, K. N. Raymond, Manganese (II) N, N′-dipyridoxylethylenediamine-N, N′-diacetate 5,5′-Bis(phosphate). Synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement. Inorg. Chem. 28, 477-485 (1989).
4. 1 response to manganese injection in the dog and rabbit. AJR Am. J. Roentgenol. 141, 193-197 (1983).
5. G. Elizondo, C. Fretz, D. D. Stark, S. M. Rocklage, S. C. Quay, D. Worah, Y.-M. Tsang, M. Chia-Mei Chen, J. T. Ferruci, Preclinical evaluation of Mn-DPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 178, 73-78 (1991).
6. R. C. Nelson, J. L. Chezmar, G. H. Thompson, J. B. Webber, M. H. Garrison, H. B. Spencer, D. L. Dillehay, Magnetic resonance imaging after arterial portography with manganese dipyridoxyl diphosphate. Invest. Radiol. 28, 335-340 (1993).
7. P. Leander, K. Golman, J. Klaveness, E. Holtz, M. Olsson, I. Leunbach, MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction. Invest. Radiol. 25, 1130- 1134 (1990).
8. G. Marchal, Y. Ni, X. Zhang, J. Yu, K. P. Lodeman, A. L. Baert, Mn-DPDP enhanced MRI in experimental bile duct obstruction. J. Comput. Assist. Tomog. 17, 290-296 (1993).
9. A. Tanimoto, B. P. Kreft, Y. Baba, L. Zhao, J. P. Finn, C. C. Compton, D. D. Stark, Evaluation of hepatocyte-specific paramagnetic contrast media for MR imaging of hepatitis. J. Magn. Reson. Imaging 3, 786-793 (1993).
10. Y. Ni, G. Marchal, E. Rummeny, X. Zhang, K. P. Lodemann, A. L. Baert, Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study. Radiology 188, 45-51 (1993).
11. K. O. Lim, D. D. Stark, P. T. Leese, A. Pfefferbaum, S. M. Rocklage, S. C. Quay, Hepatobiliary MR imaging: first human experience with Mn-DPDP. Radiology 178, 79-82 (1991).
12. J. Liou, J. K. T. Lee, J. A. Borrello, J. J. Brown, Differentiation of hepatomas from nonhepatomous masses: use of Mn-DPDP-enhanced MR images. Magn. Reson. Imag. 12, 71-79 (1994).
13. H.-B. Gehl, R. Urhahn, K. Bohndorf, P. Klever, S. Hauptmann, K.-P. Lodemann, S. Matern, V. Schumpelick, R. Gunther, Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience. Radiology 186, 795-798 (1993).
14. K. P. Aicher, M. Laniado, A. F. Kopp, E. Gronewaller, S. H. Duda, C. D. Claussen, Mn-DPDP-enhanced MR imaging of malignant liver lesions : efficacy and safety in 20 patients. J. Magn. Reson. Imaging 3, 731-737 (1993).
15. E. Rummeny, C. Ehrenheim, H. B. Gehl, B. Hamm, M. Laniado, K. P. Lodemann, E. Schmiedel. A. Steudel, Th. G. Vogl, Manganse-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors: results of clinical phase II trials in Germany including 141 patients. Invest. Radiol. 26, S142-S145 (1991).
16. M. E. Bernardino, S. W. Young, J. K. T. Lee, J. C. Weinreb, Hepatic MR imaging with Mn- DPDP : safety, image quality, and sensitivity. Radiology 183, 53-58 (1992).
17. D. Grant, K. Zech, E. Holtz, Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest. Radiol. 29, S249-S250 (1994).
18. O. H. Pomeroy, M. Wendland, S. Wagner, N. Derugin, W. W. Holt, S. M. Rocklage, S. Quay, C. B. Higgins. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate Mn-DPDP. Invest. Radiol. 24, 531-536 (1989).
19. D. M. Chauncey, H. R. Schelbert, S. E. Halper, F. Delano, M. L. McKegney, W. L. Ashburn, P. L. Hagan, Tissue distribution studies with radioactive manganese: a potential agent for myocardial imaging. J. Nucl. Med. 18, 933-936 (1977).
20. H. L. Atkins, P. Som, R. G. Fairchild, J. Hui, E. Schachner, A. Goldman, T. Ku, Myocardial positron tomography with manganese-52 m. Radiology 133, 769-774 (1979).
21. M. R. Goldman, T. J. Brady, I. L. Pykett, C. T. Burt, F. S. Buonanno, J. P. Kistler, J. H. Newhouse, W. S. Hinshaw, G. M. Pohost, Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation 66, 1012-1016 (1982).
22. S. V. Chandra, Z. Imam, Manganese induced histochemical and histological alterations in gatrointestinal mucosa of guinea pigs. Acta Pharmacol. Toxicol. (Copenh.) 33, 449-458 (1973).
23. A. Lyden, B. S. Larsson, N. G. Lindquist. Autoradiography of manganese: accumulation and retention in the pancreas. Acta Pharmacol. Toxicol. (Copehn.) 52, 205-210 (1983).
24. ++: rabbit liver and kidney. Magn. Reson. Med. 2, 159-169 (1985).
25. ++. Magn. Reson. Med. 8, 293-313 (1988).
26. S. V. Chandra, Z. Imam, N. Nagar, Significance of serum calcium, inorganic phosphatases and alcaline phosphatases in experimental manganese toxicity. Ind. Health 11, 43-51 (1973).
27. 2. in "Proc., SMR. 2nd Annual Meeting, San Francisco. 1994." p. 927.
28. ++ to murine liver. Magn. Reson. Med. 13, 44-61 (1990).
29. D. E. Ash, V. L. Schramm, Determination of free and bound manganese (II) in hepatocytes from fed and fasted rats. J. Biol. Chem. 257, 9261-9264 (1982).
30. H. Quinquampoix, G. Bacic, B. C. Loughman, R. G. Ratcliffe, Quantitative detection of the 31P-NMR detection of manganese in plant tissues. J. Exp. Botany 269, 1809-1818 (1993).
31. L. Vander Elst., Y. Van Haverbeke, J. F. Goudemant, R. N. Muller, Stability assessment of gadolinium complexes by P-31 and H-1 relaxometry. Magn. Reson. Med. 31, 437-444 (1994).
32. S. H. Koenig, R. D. Brown III, in "NMR spectroscopy of cells and organisms" (R. K. Gupta. Ed.). vol. II, p. 75, CRC Press, Boca Raton, 1987.
33. R. N. Muller, F. Maton, Y. Van Haverbeke, Characterization of MRI contrast media by nuclear magnetic relaxation spectroscopy. Diagn. Imaging Int. S62-S63 (1986).
34. S. M. Rocklage, D. Worah, S.-H. Kim, Metal ion release from paramagnetic chelates: What is tolerable? Magn. Reson. Med. 22, 216-221 (1991). See also the discussion, p. 229-232.
35. L. G. Silen, A. E. Martell, Eds., "Stability Constants of Metalion Complexes," pp. 637, 694, The Royal Society of Chemistry, London, 1964.
36. J. J. R. Frausto Da Silva, R. J. P. Williams, "The Biological Chemistry of the Elements: The Inorganic Chemistry of Life." Clarendon Press, Oxford, 1993.
37. V. L. Schramm, M. Brandt, The manganese (II) economy of rat hepatocytes. Fed. Proc. 45, 2817-2820 (1986).
38. V. M. Runge, J. A. Clanton, M. A. Foster, F. M. Smith, C. M. Lukehart, M. M. Jones, C. L. Partain, A. E. James, Paramagnetic NMR contrast agents: development and evaluation. Invest. Radiol. 19, 408-415 (1984).
39. M. Ashner, J. L. Ashner, Manganese neurotoxicity: cellular effects and blood-brain barrier transport. Neurosci. Behav. Rev. 15, 333-340 (1991).
40. R. R. Lauwerijs, A. Bernard, H. Roels, J. P. Buchet, A. Cardenas, J. P. Gennart, Health risk assessment of long-term exposure to chemicals, application to cadmium and manganese. Arch. Toxicol. S15, 97-102 (1992).
41. J. Cawte, Environmental manganese toxicity. Med. J. Aust. 154, 291-292 (1991).
42. A. Barbeau, Manganese and extrpyramidal disorders. Neurotoxicology 5, 13-36 (1984).
43. S. H. Gilani, Y. Alibhai, Teratogenicity of metals to chick embryo. J. Toxicol. Environ. Health 30, 23-31 (1990).
44. M. Joardar, A. Sharma. Comparison of clastogenicity of inorganic Mn administered in cationic and anionic forms in vivo. Mutat. Res. 240, 159-163 (1990).
45. M. De Meo, M. Laget, M. Castegnaro, G. Dumenil, Genotoxic activity of potassium permanganate in acidic solutions. Mutat. Res. 260, 295-306 (1991).
46. M. C. Newland, B. Weiss, Persistent effects of manganeses on effortful responding and their relationship to manganese accumulation in the primate globus pallidus. Toxicol. Appl. Pharmacol. 113, 87-97 (1992).
47. - - complexes. Magn. Reson. Med. 1, 496-501 (1985).